Game Plan Financial Advisors’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Game Plan Financial Advisors’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,233	Closed	-$33K	–	113
2021 Q1	$33K	Sell	1,233 -167	-12%	-$7.59K	0.02%	98
2020 Q4	$51K	Buy	+1,400	New	+$50.6K	0.04%	90
2020 Q3	–	Sell	-1,533	Closed	-$65K	–	80
2020 Q2	$65K	Buy	+1,533	New	+$103K	0.09%	53

Other funds holding EVFM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Game Plan Financial Advisors's EVFM Position: Q2 2021 in Review

Game Plan Financial Advisors sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2021, closing a stake of 1,233 shares — an estimated $33K sold.

Game Plan Financial Advisors first reported a position in EVFM in Q2 2020 and held it in 3 quarters. The position peaked at $65K in Q2 2020. 81 funds tracked by Wall St. Rank hold EVFM as of Q2 2021.

Game Plan Financial Advisors reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Game Plan Financial Advisors sold 1,233 Evofem Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $33K.
Game Plan Financial Advisors first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Game Plan Financial Advisors's Evofem Biosciences, Inc. Common Stock position peaked at $65K in Q2 2020.
81 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2021.

Based on Game Plan Financial Advisors's 13F filing for Q2 2021, filed 14 Jul 2021.